<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Praziquantel: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Praziquantel: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Praziquantel: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="9805" href="/d/html/9805.html" rel="external">see "Praziquantel: Drug information"</a> and <a class="drug drug_patient" data-topicid="12219" href="/d/html/12219.html" rel="external">see "Praziquantel: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F212673"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Biltricide</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52868002"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Biltricide</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1049480"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Anthelmintic</span></li></ul></div>
<div class="block dop drugH1Div" id="F212691"><span class="drugH1">Dosing: Pediatric</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Dosing interval and duration highly variable dependent on condition; for 3 times daily doses, intervals of 4 to 6 hours are suggested.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f61b203d-35ef-4443-a65d-8dff241f5e53">Flukes</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Flukes:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Clonorchiasis (<i>Clonorchis sinensis</i> [Chinese liver fluke]); Opisthorchiasis (<i>Opisthorchis viverrini</i> [Southeast Asian liver fluke]): Children and Adolescents: Oral: 25 mg/kg/dose 3 times daily at 4- to 6-hour intervals for 1 to 2 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.6','lexi-content-ref-CDC.8','lexi-content-ref-AAP.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.6','lexi-content-ref-CDC.8','lexi-content-ref-AAP.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Fasciolopsiasis (<i>Fasciolopsis buski </i>[intestinal fluke]):<i></i>Limited data available: Children and Adolescents: Oral: 25 mg/kg/dose 3 times daily for 1 day (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.5','lexi-content-ref-AAP.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.5','lexi-content-ref-AAP.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Paragonimiasis<i> (Paragonimus </i>spp. [lung fluke]): Limited data available: Children and Adolescents: Oral: 25 mg/kg/dose 3 times daily for 2 to 3 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.9','lexi-content-ref-AAP.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.9','lexi-content-ref-AAP.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0364cc6c-eb09-4cbe-b2b9-9e1ed140c0db">Schistosomiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Schistosomiasis (Bilharziasis):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Treatment</i> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.10','lexi-content-ref-AAP.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.10','lexi-content-ref-AAP.1'])">Ref</a></span>): <b>Note: </b>Repeat treatment may be needed in 2 to 4 weeks to increase effectiveness.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Schistosoma japonicum, <i>Schistosoma</i> mekongi</i>: Children and Adolescents: Oral: 20 mg/kg/dose 3 times daily for 1 day</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Schistosoma mansoni, <i>Schistosoma</i> haematobium, <i>Schistosoma</i> intercalatum</i>: Children and Adolescents: Oral: 20 mg/kg/dose twice daily for 1 day</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Control programs for endemic areas:</i> Limited data available: Infants, Children, and Adolescents: Oral: 40 mg/kg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-WHO.2','lexi-content-ref-WHO.3']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-WHO.2','lexi-content-ref-WHO.3'])">Ref</a></span>); a single dose of 40 mg/kg has been successfully used to treat urogenital <i>S. haematobium</i> in children 1 to 10 years of age (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27631011']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27631011'])">Ref</a></span>) and <i>S. mansoni</i> in population that included infants (age range: 5 months to 7 years) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23094120']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23094120'])">Ref</a></span>); however, pharmacokinetic data suggests a lower cure rate in infants and preschool children; one possible explanation is that higher doses may be necessary in younger patients due to pharmacokinetic/dynamic differences; in preschool children, a single dose of 60 mg/kg was successfully used in children 3 to 8 years of age in a hyperendemic area to treat <i>S. mansoni</i> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27507822']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27507822'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="45234b2d-fa87-4994-bd26-893c2ed7923b">Tapeworms</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Tapeworms:</b> Limited data available:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Diphyllobothrium latum</i> (fish), <i>Taenia saginata</i> (beef), <i>Taenia solium</i> (pork); intestinal (adult) stage: Children and Adolescents: Oral: 5 to 10 mg/kg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.3','lexi-content-ref-CDC.11','lexi-content-ref-AAP.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.3','lexi-content-ref-CDC.11','lexi-content-ref-AAP.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Dipylidium caninum</i> (dog); intestinal (adult) stage: Infants ≥6 months, Children, and Adolescents: Oral: 5 to 10 mg/kg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.4','lexi-content-ref-AAP.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.4','lexi-content-ref-AAP.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Hymenolepis nana</i> (dwarf tapeworm): Children and Adolescents: Oral: 25 mg/kg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.7']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.7'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Neurocysticercosis (<i>Taenia solium</i> [pork tapeworm]); tissue (larvae) stage: Children and Adolescents: Oral: 50 mg/kg/day for 15 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2'])">Ref</a></span>); <b>Note:</b> May be used in conjunction with antiseizure medication and/or corticosteroids.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51154927"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">No dosage adjustments are recommended</p></div>
<div class="block dohp drugH1Div" id="F51154928"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, total drug exposure in moderate to severe impairment is increased; use caution.</p></div>
<div class="block doa drugH1Div" id="F212676"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="9805" href="/d/html/9805.html" rel="external">see "Praziquantel: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c9075fec-83f3-40e1-b74f-848ecabfecfb">Clonorchiasis/opisthorchiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Clonorchiasis/opisthorchiasis:</b> Oral: 25 mg/kg/dose 3 times daily for 1 to 2 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Drugs.1','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Drugs.1','lexi-content-ref-Manu.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="794e20d1-d37e-417f-b764-9cdeb0a53a7d">Neurocysticercosis, parenchymal</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Neurocysticercosis, parenchymal (&gt;2 viable cysts) (off-label use):</b> Oral: 50 mg/kg/day in 3 divided doses (in combination with albendazole) for 10 to 14 days; may be repeated if persistent viable lesions on 6-month follow-up imaging (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24999157','lexi-content-ref-29481580','lexi-content-ref-34520139']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24999157','lexi-content-ref-29481580','lexi-content-ref-34520139'])">Ref</a></span>).<b> Note: </b>Initiate adjunctive corticosteroid therapy prior to initiation of antiparasitic therapy. Antiparasitic therapy should not be initiated in patients with untreated hydrocephalus, calcified lesions, or cysticercal encephalitis; consult an infectious diseases specialist for specific treatment recommendations (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29481580']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29481580'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0364cc6c-eb09-4cbe-b2b9-9e1ed140c0db">Schistosomiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Schistosomiasis:</b>
<b>Note:</b> Repeat treatment may be needed in 2 to 4 weeks to increase effectiveness (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.10']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.10'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>S. haematobium</i>, <i>Schistosoma intercalatum</i>, or <i>S. mansoni</i>: Oral: 40 mg/kg/day as a single dose or in 2 divided doses for 1 day (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.10','lexi-content-ref-Drugs.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.10','lexi-content-ref-Drugs.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>S. japonicum</i> or<i> S. mekongi: </i>Oral: 60 mg/kg/day in 2 or 3 divided doses for 1 day (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.10','lexi-content-ref-Drugs.1','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.10','lexi-content-ref-Drugs.1','lexi-content-ref-Manu.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="45234b2d-fa87-4994-bd26-893c2ed7923b">Tapeworms</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Tapeworms (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">Dwarf tapeworm <i>(Hymenolepis nana): </i>
<b>Oral:</b> 25 mg/kg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-Drugs.1','lexi-content-ref-8602186']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-Drugs.1','lexi-content-ref-8602186'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Fish tapeworm (<i>Diphyllobothrium</i> spp.), beef or pork tapeworm (<i>Taenia</i> spp.): <b>Oral:</b> 5 to 10 mg/kg as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-Drugs.1','lexi-content-ref-8602186']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-Drugs.1','lexi-content-ref-8602186'])">Ref</a></span>); 10 mg/kg may have a higher cure rate for taeniasis (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-PAHO.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-PAHO.1'])">Ref</a></span>).</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dora drugH1Div" id="F50991149"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">No dosage adjustment necessary.</p></div>
<div class="block doha drugH1Div" id="F50988492"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in manufacturer's labeling. However, total drug exposure in moderate-to-severe impairment is increased.</p></div>
<div class="block adr drugH1Div" id="F212651"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:0em;">Frequency not defined. May be more frequent and/or serious in patients with a heavy worm burden.</p>
<p style="text-indent:-2em;margin-left:2em;">Central nervous system: Dizziness, headache, malaise</p>
<p style="text-indent:-2em;margin-left:2em;">Dermatologic: Urticaria</p>
<p style="text-indent:-2em;margin-left:2em;">Gastrointestinal: Abdominal distress, nausea</p>
<p style="text-indent:-2em;margin-left:2em;">Miscellaneous: Fever</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%, postmarketing and/or case reports: Abdominal pain, anorexia, atrioventricular block, bloody diarrhea, bradycardia, cardiac arrhythmia, drowsiness, ectopic beats, eosinophilia, fatigue, hypersensitivity, hypersensitivity reaction, increased liver enzymes (minimal), myalgia, paradoxical reaction (in schistosomiasis), polyserositis, pruritus, seizure, serum sickness (in schistosomiasis; Jarisch-Herxheimer-like reaction), skin rash, ventricular fibrillation, vertigo, vomiting, weakness</p></div>
<div class="block coi drugH1Div" id="F212661"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">Hypersensitivity to praziquantel or any component of the formulation; ocular cysticercosis; concomitant administration with strong cytochrome P450 3A enzyme (CYP3A) inducers, such as rifampin.</p>
<p style="text-indent:-2em;margin-left:2em;">Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block war drugH1Div" id="F212648"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Cardiac arrhythmias: Monitor patients with cardiac arrhythmias during treatment; bradycardia, ectopic rhythms, ventricular fibrillation, and AV blocks have been observed with praziquantel administration.</p>
<p style="text-indent:-2em;margin-left:4em;">• Central nervous system effects: Praziquantel may exacerbate central nervous system pathology due to schistosomiasis, paragonimiasis, or <i>Taenia solium</i> cysticercosis. Assess whether the potential benefit justifies the potential risk in patients with a history of seizures and/or other signs of potential central nervous system involvement such as subcutaneous nodules suggestive of cysticercosis.</p>
<p style="text-indent:-2em;margin-left:4em;">• Hepatic impairment: Use with caution in patients with moderate to severe hepatic impairment; reduced liver drug metabolism may result in higher and longer lasting plasma concentrations of unmetabolized praziquantel.</p>
<p style="text-indent:-2em;margin-left:4em;">• Neurocysticercosis: Appropriate use: Antiparasitic therapy may worsen symptoms of neurocysticercosis by inducing an inflammatory response; adjunctive corticosteroid therapy should be started before initiation of antiparasitic therapy. Antiparasitic therapy should not be initiated in patients with untreated hydrocephalus, calcified lesions, or cysticercal encephalitis. Perform funduscopic exam prior to initiation of antiparasitic therapy to exclude intraocular cysticerci; antiparasitic therapy may lead to blindness in some cases with unsuspected intraocular parasites (IDSA/ASTMH [White 2018]).</p>
<p style="text-indent:-2em;margin-left:4em;">• Schistosomiasis: Praziquantel may not be effective against migrating schistosomulae; observational data indicate that praziquantel treatment in the acute phase of the infection may not prevent progression from asymptomatic to acute schistosomiasis, or from asymptomatic/acute disease to chronic disease. In addition, use in patients with schistosomiasis may be associated with clinical deterioration such as paradoxical reactions or serum sickness Jarisch-Herxheimer-like reactions, which is a sudden inflammatory immune response likely caused by the release of schistosomal antigens. Such reactions typically occur during the acute disease phase, and may lead to life-threatening events such as respiratory failure, encephalopathy, papilledema, and/or cerebral vasculitis.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Patient information: Patients should be instructed to not drive or operate machinery on the day of treatment and the day after treatment.</p></div>
<div class="block foc drugH1Div" id="F212657"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Biltricide: 600 mg [scored]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 600 mg</p></div>
<div class="block geq drugH1Div" id="F212644"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F212663"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Biltricide Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">600 mg (per each): $99.65</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Praziquantel Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">600 mg (per each): $89.68</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52868003"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Biltricide: 600 mg</p></div>
<div class="block admp drugH1Div" id="F52613648"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Oral: Administer tablets with water during meals; tablets should be promptly swallowed whole (do not chew) to avoid bitter taste that may cause gagging or vomiting; tablets are scored and may be halved or quartered. Tablets may be crushed or disintegrated and mixed with semi-solid food or liquid; use within 1 hour of mixing. Studies in infants and young children have crushed the tablets and mixed in a variety of liquids (eg, orange juice, honey) to reduce the bitter taste (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-WHO.3']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-WHO.3'])">Ref</a></span>).</p></div>
<div class="block adm drugH1Div" id="F9603850"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Oral:</b> According to the manufacturer, administer tablets with water during meals; however, some experts prefer administration 30 minutes before or 2 hours after a meal when treating tapeworm infections (eg, taeniasis) (PAHO 2021). Tablets should be promptly swallowed to avoid bitter taste that may cause gagging or vomiting. Tablets may be halved or quartered; do not chew. Tablets may be crushed or disintegrated and mixed with semi-solid food or liquid; use within 1 hour of mixing. Tablets are scored and may be split into four 150 mg segments.</p></div>
<div class="block sts drugH1Div" id="F10822185"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Store below 30°C (86°F).</p></div>
<div class="block usep drugH1Div" id="F53568498"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Treatment of schistosomiasis caused by all species of <i>Schistosoma</i>; treatment of clonorchiasis and opisthorchiasis due to liver flukes (All indications: FDA approved in ages ≥1 year and adults); has also been used in the treatment of cysticercosis and many intestinal tapeworm and trematode infections</p></div>
<div class="block cyt drugH1Div" id="F212694"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">
<b>Substrate</b> of CYP3A4 (major); <b>Note:</b> Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential</p></div>
<div class="block dri drugH1Div" id="F212653"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Chloroquine: May decrease the serum concentration of Praziquantel.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Cimetidine: May increase the serum concentration of Praziquantel.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Clofazimine: May increase the serum concentration of CYP3A4 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">CYP3A4 Inducers (Moderate): May decrease the serum concentration of Praziquantel. Management: Consider alternatives to this combination whenever possible. If combined, monitor closely for reduced praziquantel efficacy. If possible, stop the moderate CYP3A4 inducer 2 to 4 weeks before praziquantel initiation.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">CYP3A4 Inducers (Strong): May decrease the serum concentration of Praziquantel.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">CYP3A4 Inhibitors (Moderate): May increase the serum concentration of Praziquantel.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">CYP3A4 Inhibitors (Strong): May increase the serum concentration of Praziquantel.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Fexinidazole: May increase the serum concentration of CYP3A4 Substrates (High risk with Inhibitors).<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Fusidic Acid (Systemic): May increase the serum concentration of CYP3A4 Substrates (High risk with Inhibitors).<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Grapefruit Juice: May increase the serum concentration of Praziquantel.<i> Risk C: Monitor therapy</i></p></div>
<div class="block dic drugH1Div" id="F58432789"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:0em;display:inline">Manufacturer recommends taking with meals; however, some experts prefer taking on an empty stomach (ie, 30 minutes before or 2 hours after a meal) when treating tapeworm infections (eg, taeniasis) (PAHO 2021).</p></div>
<div class="block pri drugH1Div" id="F10822164"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Based on available data, an increased risk of adverse fetal or maternal outcomes has not been observed following use of praziquantel for the treatment of <i>Schistosoma</i> infection during pregnancy (Friedman 2018).</p>
<p style="text-indent:0em;margin-top:2em;">In areas where schistosomiasis and soil-transmitted helminthiasis is endemic, the World Health Organization recommends treatment with praziquantel during any trimester of pregnancy (WHO 2006). Non-emergent treatment of neurocysticercosis can be delayed until after pregnancy (IDSA/ASTMH [White 2018]).</p></div>
<div class="block mopp drugH1Div" id="F53568477"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Liver function tests; monitor patients with cardiac irregularities during treatment; monitor for seizures; culture urine or feces for ova prior to instituting therapy</p></div>
<div class="block pha drugH1Div" id="F212647"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Increases the cell permeability to calcium in schistosomes, causing strong contractions and paralysis of worm musculature leading to detachment of suckers from the blood vessel walls and to dislodgment</p></div>
<div class="block phk drugH1Div" id="F212660"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Absorption: Oral: 80% </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Distribution: CSF concentration is 14% to 20% of plasma concentration</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Protein binding: ~80% </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Metabolism: Extensive first-pass effect; metabolized by the liver to hydroxylated and conjugated metabolites</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Half-life elimination: Parent drug: 0.8 to 1.5 hours; Metabolites: 4.5 hours </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Time to peak, serum: 1 to 3 hours </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Excretion: Urine ~80% (&gt;99% as metabolites)</p></div>
<div class="block phksp drugH1Div" id="F51219985"><span class="drugH1">Pharmacokinetics: Additional Considerations (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Altered kidney function: Excretion may be delayed in patients with renal impairment, but accumulation of unchanged drug would not be expected.</p>
<p style="text-indent:-2em;margin-left:2em;">Hepatic function impairment: C<sub>max</sub>, AUC, and half-life were significantly elevated in patients with moderate to severe liver impairment.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F212664"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Prazitral</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | Cesol</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Praziquantel generichealth</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Biltricide</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Cestox | Cisticid | Farmanguinhos praziquantel</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Cesol</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Cesol</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | Cesol</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | Cesol | Cysticide</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | Prazican</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Belicide | Bilharzid | Bilharzin | Bilharzine | Biltricide | Distocide | Epiquantel</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Bermoxel | Pzq</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | Praziquantel Dci</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Biltricide</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | Distocide</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Prazikuantel</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Biltricide</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Prazine | Zenticide</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Distocide | Epiquantel</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Biltricide</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | Biltrized | Prazicide | Prazitel</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Antoma | Biltricide</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Biltricide</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Biltricid | Biltricide | Cesol | Cysticide | Prazivac</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Biltricid | Biltricide | Cesol</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Cesol | Cisticid | Tecprazin</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Distoside</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">N &amp; n praziquantel | Prizilcide | Ziltrix</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Biltricide</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Biltricide euromedica</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Biltricide</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Cisticid | Helmiben | Prazimek</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Fluxide</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | Cesol</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Biltricide</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Bermoxel | Cisticid | Cysticide</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Epiquantel</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Azynox | Biltricid</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Distocide</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Biltricide</span>;</li>
<li>
<span class="countryCode">(SL)</span> <span class="country">Sierra Leone</span><span class="countrySeparator">: </span><span class="drugName">Pratel</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | C.R.Cide | Opticide | Pontel | Praquantel | Prasikon | Prasix | Prazi | Prazig | Prazite | V Day Prazide | Wormicide | Z-queen | Zentozide</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | Kaicide</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Biltricid | Biltricide</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Agopraz | Prazitel</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Praziquantel Dispert</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Cestox | Cisticid</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Biltricide | Cysticide</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Prazikant</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-AAP.1">
<a name="AAP.1"></a>American Academy of Pediatrics (AAP). In: Kimberlin DW, Brady MT, Jackson MA, Long SA, eds. <i>Red Book: 2018 Report of the Committee on Infectious Diseases</i>. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018.</div>
</li>
<li>
<div class="reference">
                  Biltricide (praziquantel) [prescribing information]. Whippany, NJ: Bayer HealthCare Pharmaceuticals Inc; December 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27507822">
<a name="27507822"></a>Bustinduy AL, Waterhouse D, de Sousa-Figueiredo JC, et al. Population pharmacokinetics and pharmacodynamics of praziquantel in Ugandan children with intestinal schistosomiasis: higher dosages are required for maximal efficacy. <i>MBio</i>. 2016;7(4). pii: e00227-16.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/27507822/pubmed" id="27507822" target="_blank">27507822</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.6">
<a name="CDC.6"></a>Centers for Disease Control and Prevention (CDC). Parasites - Clonorchiasis. Centers for Disease Control and Prevention website. <a href="https://www.cdc.gov/parasites/clonorchis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/clonorchis/health_professionals/index.html</a>. Updated March 1, 2018a. Accessed March 15, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.2">
<a name="CDC.2"></a>Centers for Disease Control and Prevention (CDC). Parasites - Cysticercosis. Centers for Disease Control and Prevention website. <a href="https://www.cdc.gov/parasites/cysticercosis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/cysticercosis/health_professionals/index.html</a>. Updated November 6, 2017. Accessed February 8, 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.3">
<a name="CDC.3"></a>Centers for Disease Control and Prevention (CDC). Parasites - Diphyllobothrium. Centers for Disease Control and Prevention website. <a href="https://www.cdc.gov/parasites/diphyllobothrium/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/diphyllobothrium/health_professionals/index.html</a>. Updated January 10, 2012a. Accessed April 8, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.4">
<a name="CDC.4"></a>Centers for Disease Control and Prevention (CDC). Parasites - Dipylidium Infection. Centers for Disease Control and Prevention website. <a href="https://www.cdc.gov/parasites/dipylidium/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/dipylidium/health_professionals/index.html</a>. Updated November 8, 2016. Accessed April 5, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.5">
<a name="CDC.5"></a>Centers for Disease Control and Prevention (CDC). Parasites - Fasciolopsiasis. Centers for Disease Control and Prevention website. <a href="https://www.cdc.gov/parasites/fasciolopsis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/fasciolopsis/health_professionals/index.html</a>. Update January 10, 2012b. Accessed April 8, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.1">
<a name="CDC.1"></a>Centers for Disease Control and Prevention (CDC). Parasites. <a href="https://www.cdc.gov/parasites/index.html" target="_blank">https://www.cdc.gov/parasites/index.html</a>. Updated August 19, 2022. Accessed August 31, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.7">
<a name="CDC.7"></a>Centers for Disease Control and Prevention (CDC). Parasites - Hymenolepis. Centers for Disease Control and Prevention website. <a href="https://www.cdc.gov/parasites/hymenolepis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/hymenolepis/health_professionals/index.html</a>. Updated January 10, 2012c. Accessed April 5, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.8">
<a name="CDC.8"></a>Centers for Disease Control and Prevention (CDC). Parasites - Opisthorchis Infection. Centers for Disease Control and Prevention website. <a href="https://www.cdc.gov/parasites/opisthorchis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/opisthorchis/health_professionals/index.html</a>. Updated March 1, 2018b. Accessed March 15, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.9">
<a name="CDC.9"></a>Centers for Disease Control and Prevention (CDC). Parasites - Paragonimiasis, Centers for Disease Control and Prevention website. <a href="https://www.cdc.gov/parasites/paragonimus/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/paragonimus/health_professionals/index.html</a>. Updated January 10, 2013a. Accessed April 5, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.10">
<a name="CDC.10"></a>Centers for Disease Control and Prevention (CDC). Parasites - Schistosomiasis. Centers for Disease Control and Prevention website. <a href="https://www.cdc.gov/parasites/schistosomiasis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/schistosomiasis/health_professionals/index.html</a>. Updated June 25, 2018c. Accessed April 10, 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.11">
<a name="CDC.11"></a>Centers for Disease Control and Prevention (CDC). Parasites - Taeniasis. Centers for Disease Control and Prevention website. <a href="https://www.cdc.gov/parasites/taeniasis/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/taeniasis/health_professionals/index.html</a>. Updated January 10, 2013b. Accessed April 8, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Drugs.1">
<a name="Drugs.1"></a>Drugs for parasitic infections. <i>Med Lett Drugs Ther</i>. 2013;11(suppl):e1-31.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29403101">
<a name="29403101"></a>Friedman JF, Olveda RM, Mirochnick MH, Bustinduy AL, Elliott AM. Praziquantel for the treatment of schistosomiasis during human pregnancy. <i>Bull World Health Organ</i>. 2018;96(1):59-65. doi: 10.2471/BLT.17.198879.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/29403101/pubmed" id="29403101" target="_blank">29403101</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12364377">
<a name="12364377"></a>Garcia HH, Evans CAW, Nash TE, et al, “Current Consensus Guidelines for Treatment of Neurocysticercosis,” <i>Clin Microbiol Rev</i>, 2002, 15(4):747-56.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/12364377/pubmed" id="12364377" target="_blank">12364377</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24999157">
<a name="24999157"></a>Garcia HH, Gonzales I, Lescano AG, et al; Cysticercosis Working Group in Peru. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. <i>Lancet Infect Dis</i>. 2014;14(8):687-695. doi: 10.1016/S1473-3099(14)70779-0.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/24999157/pubmed" id="24999157" target="_blank">24999157</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26984901">
<a name="26984901"></a>Garcia HH, Lescano AG, Gonzales I, et al; Cysticercosis Working Group in Peru. Cysticidal efficacy of combined treatment with praziquantel and albendazole for parenchymal brain cysticercosis. <i>Clin Infect Dis</i>. 2016;62(11):1375-1379. doi: 10.1093/cid/ciw134.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/26984901/pubmed" id="26984901" target="_blank">26984901</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19325515">
<a name="19325515"></a>Kaur S, Singhi P, Singhi S, et al. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. <i>Pediatr Infect Dis J</i>. 2009;28(5):403-406.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/19325515/pubmed" id="19325515" target="_blank">19325515</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8602186">
<a name="8602186"></a>Liu LX, Weller PF. Antiparasitic Drug. <i>N Engl J Med</i>. 1996;334(18):1178-1184. doi:10.1056/NEJM199605023341808<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/8602186/pubmed" id="8602186" target="_blank">8602186</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-PAHO.1">
<a name="PAHO.1"></a>Pan American Health Organization (PAHO). Guideline for the preventive chemotherapy for the control of Taenia solium Taeniasis. https://iris.paho.org/bitstream/handle/10665.2/54800/9789275123720_eng.pdf?sequence=1&amp;isAllowed=y. Updated September 2021. Accessed August 31, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-575330">
<a name="575330"></a>Pütter J, Held F. Quantitative studies on the occurrence of praziquantel in milk and plasma of lactating women. <i>Eur J Drug Metab Pharmacokinet</i>. 1979;4(4):193-198. doi: 10.1007/BF03189426.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/575330/pubmed" id="575330" target="_blank">575330</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Manu.1">
<a name="Manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23094120">
<a name="23094120"></a>Sousa-Figueiredo JC, Betson M, Atuhaire A, et al. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. <i>PLoS Negl Trop Dis</i>. 2012;6(10):e1864.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/23094120/pubmed" id="23094120" target="_blank">23094120</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27631011">
<a name="27631011"></a>Wami WM, Nausch N, Midzi N, et al. Comparative assessment of health benefits of praziquantel treatment of urogenital schistosomiasis in preschool and primary school-aged children. <i>Biomed Res Int</i>. 2016:9162631.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/27631011/pubmed" id="27631011" target="_blank">27631011</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29481580">
<a name="29481580"></a>White AC Jr, Coyle CM, Rajshekhar V, et al. Diagnosis and treatment of neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). <i>Clin Infect Dis</i>. 2018;66(8):e49-e75. doi: 10.1093/cid/cix1084.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/29481580/pubmed" id="29481580" target="_blank">29481580</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.1">
<a name="WHO.1"></a>World Health Organization (WHO). Breastfeeding and maternal medication: recommendations for drugs in the Eleventh WHO Model List of Essential Drugs. Geneva: World Health Organization; 2002. Available at: http://www.who.int/iris/handle/10665/62435. Accessed January 25, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.2">
<a name="WHO.2"></a>World Health Organization (WHO). Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization; 2006. Available at: http://www.who.int/iris/handle/10665/43545. Accessed January 25, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.3">
<a name="WHO.3"></a>World Health Organization (WHO). Report of a meeting to review the results of studies on the treatment of schistosomiasis in pre-school-age children. Geneva: World Health Organization; 2010. Available at: https://www.who.int/neglected_diseases/resources/9789241501880/en/.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34520139">
<a name="34520139"></a>World Health Organization (WHO). WHO guidelines on management of Taenia solium neurocysticercosis. Geneva: World Health Organization; 2021.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/praziquantel-pediatric-drug-information/abstract-text/34520139/pubmed" id="34520139" target="_blank">34520139</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 12721 Version 178.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
